(19)
(11) EP 4 430 086 A1

(12)

(43) Date of publication:
18.09.2024 Bulletin 2024/38

(21) Application number: 22893868.4

(22) Date of filing: 11.11.2022
(51) International Patent Classification (IPC): 
C07K 19/00(2006.01)
A61K 38/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 38/1774; C07K 14/70503; C07K 14/70575; C07K 2319/30; C07K 2319/00
(86) International application number:
PCT/US2022/079702
(87) International publication number:
WO 2023/086929 (19.05.2023 Gazette 2023/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 12.11.2021 US 202163278567 P
11.08.2022 US 202263371083 P

(71) Applicant: Shattuck Labs, Inc.
Austin, TX 78701 (US)

(72) Inventors:
  • PANDITE, Arundathy
    Austin, TX 78701 (US)
  • RANGWALA, Fatima
    Austin, TX 78701 (US)
  • LAMPKIN, Thomas
    Austin, TX 78701 (US)
  • SCHREIBER, Taylor
    Austin, TX 78701 (US)
  • FROMM, George
    Austin, TX 78701 (US)
  • DE SILVA, Suresh
    Austin, TX 78701 (US)

(74) Representative: Sagittarius IP 
Marlow International Parkway
Marlow SL7 1YL
Marlow SL7 1YL (GB)

   


(54) SIRP1A - AND CD40L-BASED CHIMERIC PROTEINS